Retraction Note to: LATS2 overexpression attenuates the therapeutic resistance of liver cancer HepG2 cells to sorafenib‑mediated death via inhibiting the AMPK–Mfn2 signaling pathway

Retraction Note to: LATS2 overexpression attenuates the therapeutic resistance of liver cancer HepG2 cells to sorafenib‑mediated death via inhibiting the AMPK–Mfn2 signaling pathway

The editor has retracted this article [1] because Fig. 2f has been duplicated from Fig. 6j in a previously published article [2]. In addition, the article contains sections that substantially overlap with a previously published article [3]. The data reported in this article are therefore unreliable....

Full description

Bibliographic Details
Main Authors: Jie Song, Wei Zhao, Chang Lu, Xue Shao
Format: Article
Language:English
Published: BMC 2019-12-01
Series:Cancer Cell International
Online Access:https://doi.org/10.1186/s12935-019-1084-7
id doaj-f98ee01de9054fbca4afe9849c1d8b5c
record_format Article
spelling doaj-f98ee01de9054fbca4afe9849c1d8b5c2021-01-03T12:09:17ZengBMCCancer Cell International1475-28672019-12-011911110.1186/s12935-019-1084-7Retraction Note to: LATS2 overexpression attenuates the therapeutic resistance of liver cancer HepG2 cells to sorafenib‑mediated death via inhibiting the AMPK–Mfn2 signaling pathwayJie Song0Wei Zhao1Chang Lu2Xue Shao3Department of Hepatopancreatobiliary Medicine, The Second Hospital of Jilin UniversityDepartment of Pharmacy, The Second Hospital of Jilin UniversityDepartment of Anesthesiology, The Second Hospital of Jilin UniversityDepartment of Hepatopancreatobiliary Medicine, The Second Hospital of Jilin UniversityThe editor has retracted this article [1] because Fig. 2f has been duplicated from Fig. 6j in a previously published article [2]. In addition, the article contains sections that substantially overlap with a previously published article [3]. The data reported in this article are therefore unreliable.https://doi.org/10.1186/s12935-019-1084-7
collection DOAJ
language English
format Article
sources DOAJ
author Jie Song
Wei Zhao
Chang Lu
Xue Shao
spellingShingle Jie Song
Wei Zhao
Chang Lu
Xue Shao
Retraction Note to: LATS2 overexpression attenuates the therapeutic resistance of liver cancer HepG2 cells to sorafenib‑mediated death via inhibiting the AMPK–Mfn2 signaling pathway
Cancer Cell International
author_facet Jie Song
Wei Zhao
Chang Lu
Xue Shao
author_sort Jie Song
title Retraction Note to: LATS2 overexpression attenuates the therapeutic resistance of liver cancer HepG2 cells to sorafenib‑mediated death via inhibiting the AMPK–Mfn2 signaling pathway
title_short Retraction Note to: LATS2 overexpression attenuates the therapeutic resistance of liver cancer HepG2 cells to sorafenib‑mediated death via inhibiting the AMPK–Mfn2 signaling pathway
title_full Retraction Note to: LATS2 overexpression attenuates the therapeutic resistance of liver cancer HepG2 cells to sorafenib‑mediated death via inhibiting the AMPK–Mfn2 signaling pathway
title_fullStr Retraction Note to: LATS2 overexpression attenuates the therapeutic resistance of liver cancer HepG2 cells to sorafenib‑mediated death via inhibiting the AMPK–Mfn2 signaling pathway
title_full_unstemmed Retraction Note to: LATS2 overexpression attenuates the therapeutic resistance of liver cancer HepG2 cells to sorafenib‑mediated death via inhibiting the AMPK–Mfn2 signaling pathway
title_sort retraction note to: lats2 overexpression attenuates the therapeutic resistance of liver cancer hepg2 cells to sorafenib‑mediated death via inhibiting the ampk–mfn2 signaling pathway
publisher BMC
series Cancer Cell International
issn 1475-2867
publishDate 2019-12-01
description The editor has retracted this article [1] because Fig. 2f has been duplicated from Fig. 6j in a previously published article [2]. In addition, the article contains sections that substantially overlap with a previously published article [3]. The data reported in this article are therefore unreliable.
url https://doi.org/10.1186/s12935-019-1084-7
work_keys_str_mv AT jiesong retractionnotetolats2overexpressionattenuatesthetherapeuticresistanceoflivercancerhepg2cellstosorafenibmediateddeathviainhibitingtheampkmfn2signalingpathway
AT weizhao retractionnotetolats2overexpressionattenuatesthetherapeuticresistanceoflivercancerhepg2cellstosorafenibmediateddeathviainhibitingtheampkmfn2signalingpathway
AT changlu retractionnotetolats2overexpressionattenuatesthetherapeuticresistanceoflivercancerhepg2cellstosorafenibmediateddeathviainhibitingtheampkmfn2signalingpathway
AT xueshao retractionnotetolats2overexpressionattenuatesthetherapeuticresistanceoflivercancerhepg2cellstosorafenibmediateddeathviainhibitingtheampkmfn2signalingpathway
_version_ 1724350778583285760

Similar Items